Soligenix Inc (SNGX) Actualités

Form 8-K - Current report

Soligenix Announces Reverse Stock Split

Soligenix Announces Reverse Stock Split PR Newswire PRINCETON, N.J., May 31, 2024 Common Stock Will Begin...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting PR Newswire PRINCETON, N.J., May...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting PR...

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split PR Newswire PRINCETON, N.J., May...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon

NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) --  PRISM MarketView presents an in-depth interview with Dr...

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference PR...

Soligenix Encourages Stockholders to Vote Prior to Annual Meeting

Soligenix Encourages Stockholders to Vote Prior to Annual Meeting PR Newswire PRINCETON, N.J., May 20, 2024...

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma...